company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,463349000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,463349000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,463349000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,135742000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22640000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,53349000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,162797000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1653000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,376181000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,87168000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,22218000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1548000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1526000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19144000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,68024000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,25536000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,42488000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,42488000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,42488000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,249900000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.17
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,249900000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,249900000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 17:14:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.17
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,444988000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,444988000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,444988000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,120631000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21202000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,52862000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,156093000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4419000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,355207000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,89781000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,27592000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,982000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4112000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22498000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,67283000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,29348000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,37935000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,37935000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,37935000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,237100000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,252900000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,237100000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 14:34:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,374546000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,374546000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,374546000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,114341000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25666000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,32679000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,132651000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1162000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-677000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,305822000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,68724000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7293000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2076000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2239000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7130000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,61594000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,22374000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,39220000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,39220000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,39220000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,245100000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,245100000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,245100000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q3,2010-07-01,2010-09-30,2010-11-05 17:14:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,370903000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,370903000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,370903000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,131829000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33174000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,53903000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,119027000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4852000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,342785000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28118000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9731000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,736000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10747000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1752000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,29870000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11882000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17988000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17988000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17988000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,257000000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.07
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,257000000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.07
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,257000000.0
KING PHARMACEUTICALS INC,KG,,0001047699,2010.0,Q2,2010-04-01,2010-06-30,2010-08-09 14:34:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.07
